SS

Seeta Soumya Vadavalli

Active Director Director DIN 10902867
DIN 10902867 First appointment Jan 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Seeta Soumya Vadavalli

Data last updated:

Seeta Soumya Vadavalli is a Director at Vacciner Diagnostic Wale Private Limited (since 2025) and Director at Vacciner Log Private Limited (since 2025).

DIN 10902867
Primary Designation Director
First Appointment 10 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Nov 20252025Active
Vacciner Log Private Limited U62013TS2025PTC192794
Director10 Jan 20252025Active

Board colleagues of Seeta Soumya Vadavalli

Directorship timeline

Open interactive timeline →
Vacciner Diagnostic Wale Private Limited
Vacciner Log Private Limited
Premium access

Shareholding and investment profile for Seeta Soumya Vadavalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seeta Soumya Vadavalli

Seeta Soumya Vadavalli currently holds 2 directorships: Vacciner Diagnostic Wale Private Limited (Director, since 20 Nov 2025); Vacciner Log Private Limited (Director, since 10 Jan 2025).

Seeta Soumya Vadavalli was first appointed on 10 Jan 2025 as Director at Vacciner Log Private Limited.

The current boards of Seeta Soumya Vadavalli's companies include Sravan Kumar Pulla (Vacciner Diagnostic Wale Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available